180 related articles for article (PubMed ID: 11332909)
1. Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins.
Araneda M; Krishnan V; Hall K; Kalbfleisch J; Krishnaswamy G; Krishnan K
South Med J; 2001 Apr; 94(4):417-20. PubMed ID: 11332909
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis.
Hsu HC; Tsai WH; Jiang ML; Ho CH; Hsu ML; Ho CK; Wang SY
J Lab Clin Med; 1999 Oct; 134(4):392-7. PubMed ID: 10521086
[TBL] [Abstract][Full Text] [Related]
3. Circulating thrombopoietin in clonal versus reactive thrombocytosis.
Karakuş S; Ozcebe OI; Haznedaroğlu IC; Göker H; Ozatli D; Koşar A; BüyükaşIk Y; Ertuğrul D; SayInalp N; KirazlI S; Dündar SV
Hematology; 2002 Feb; 7(1):9-12. PubMed ID: 12171772
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders.
Ceresa IF; Noris P; Ambaglio C; Pecci A; Balduini CL
Platelets; 2007 Dec; 18(8):579-82. PubMed ID: 18041648
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura.
Lin CY; Yang YH; Lee CC; Huang CL; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2006 Dec; 39(6):476-82. PubMed ID: 17164950
[TBL] [Abstract][Full Text] [Related]
6. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
7. Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
Kuku I; Bayraktar MR; Kaya E; Erkurt MA; Bayraktar N; Cikim K; Aydogdu I
Mediators Inflamm; 2005 Aug; 2005(3):171-4. PubMed ID: 16106104
[TBL] [Abstract][Full Text] [Related]
8. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.
Liuzzo G; Santamaria M; Biasucci LM; Narducci M; Colafrancesco V; Porto A; Brugaletta S; Pinnelli M; Rizzello V; Maseri A; Crea F
J Am Coll Cardiol; 2007 Jan; 49(2):185-94. PubMed ID: 17222729
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced urticaria--activity of selected cytokines and acute phase proteins in plasma.
Czelej D; Chodorowska G; Lechowska-Mazur I
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):38-42. PubMed ID: 15314956
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis.
Uppenkamp M; Makarova E; Petrasch S; Brittinger G
Ann Hematol; 1998 Nov; 77(5):217-23. PubMed ID: 9858147
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma.
Chodorowska G; Czelej D
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):43-7. PubMed ID: 15314957
[TBL] [Abstract][Full Text] [Related]
13. Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels.
Español I; Hernández A; Cortés M; Mateo J; Pujol-Moix N
Haematologica; 1999 Apr; 84(4):312-6. PubMed ID: 10190944
[TBL] [Abstract][Full Text] [Related]
14. [C-reactive protein in differential diagnosis of primary thrombocytosis].
Pérez Encinas MM; Bello López JL; Pérez Crespo S; Lete Achirica I
Med Clin (Barc); 1995 Apr; 104(12):441-3. PubMed ID: 7739278
[TBL] [Abstract][Full Text] [Related]
15. Serum thrombopoietin levels in patients with reactive thrombocytosis due to lung cancer and in patients with essential thrombocythemia.
Werynska B; Ramlau R; Podolak-Dawidziak M; Jankowska R; Prajs I; Usnarska-Zubkiewicz L; Kuliczkowski K
Neoplasma; 2003; 50(6):447-51. PubMed ID: 14689068
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases.
Panteli KE; Hatzimichael EC; Bouranta PK; Katsaraki A; Seferiadis K; Stebbing J; Bourantas KL
Br J Haematol; 2005 Sep; 130(5):709-15. PubMed ID: 16115126
[TBL] [Abstract][Full Text] [Related]
17. Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis.
Unsal E; Aksaray S; Köksal D; Sipit T
Postgrad Med J; 2005 Sep; 81(959):604-7. PubMed ID: 16143693
[TBL] [Abstract][Full Text] [Related]
18. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M
Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384
[TBL] [Abstract][Full Text] [Related]
19. Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis.
Wang JC; Chen C; Novetsky AD; Lichter SM; Ahmed F; Friedberg NM
Am J Med; 1998 May; 104(5):451-5. PubMed ID: 9626028
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of interleukin-18 (IL-18), interleukin-1beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis.
Pietruczuk A; Swierzbińska R; Pancewicz S; Pietruczuk M; Hermanowska-Szpakowicz T
Infection; 2006 Jun; 34(3):158-62. PubMed ID: 16804660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]